To further examine whether miR-125b would induce EMT, breast cancer cell lines MDA-MB-231 and MCF-7/ADR were used to observe the variation of vimentin and α-SMA because MCF-7 is vimentin-negative cell line. The gene discussed is ACTA1; the disease is breast carcinoma.